Login / Signup

National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19.

Maryam Sadat MirenayatAtefeh AbediniArda KianiAlireza EslaminejadParisa Adimi NaghanMajid MalekmohammadJalal HeshmatniaSeyed Alireza NadjiEsmaeil IdaniReyhaneh ZahiriSomayeh LookzadehHakimeh SheikhzadeFarzaneh DastanMihan Porabdollah ToutkaboniMitra Sadat RezaeiElham AskariPayam TabarsiMajid MarjaniAfshin MoniriSeyed Mohammad Reza HashemianBehrooz FarzaneganZahra AbtahianFatemeh YassariNazanin MansouriDavood MansouriMaryam VasheghaniBabak MansourafsharMojtaba Mokhber DezfoliSalman SoleimaniSharareh SeifiFarah NaghashzadehAtefeh FakharianMohammad VarahramHamidreza JamaatiAlireza ZaliAli Akbar Velayati
Published in: Iranian journal of pharmaceutical research : IJPR (2022)
More than a year after the onset of the coronavirus disease pandemic in 2019, the disease remains a major global health issue. During this time, health organizations worldwide have tried to provide integrated treatment guidelines to control coronavirus disease 2019 (COVID-19) at different levels. However, due to the novel nature of the disease and the emergence of new variants, medical teams' updating medical information and drug prescribing guidelines should be given special attention. This version is an updated instruction of the National Research Institute of Tuberculosis and Lung Disease (NRITLD) in collaboration with a group of specialists from Masih Daneshvari Hospital in Tehran, Iran, which is provided to update the information of caring clinicians for the treatment and care of COVID-19 hospitalized patients.
Keyphrases